India's TDB is supporting Helix Cell Therapeutics to develop an affordable, dual-targeting CAR-T therapy for multiple myeloma, aiming to improve treatment outcomes via Indo-Singapore collaboration.

As the cosmetics industry continues to pursue more sustainable, high-performance, and biotechnology-driven ingredients, plant ...

Perth biotech Syngenis is using artificial intelligence to slash the time and cost of discovering RNA therapies and ...

The Technology Development Board (TDB) has begun disbursing the first tranche of the Rs 1 lakh crore Research and Development ...

Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a ...

Pakistan is looking to expand exports of elite buffalo embryos and dairy genetics to China as the country seeks new ...

UMeWorld Inc. (OTCID:UMEW) today announced its unaudited financial results for the second fiscal quarter ended March 31, 2026, reflecting accelerating commercial activity across its consumer wellness ...

Following a successful 6-month feeding study, the FDA has issued a letter of no objection for a precision ...

Q1 2026 Earnings Call May 13, 2026 5:00 PM EDTCompany ParticipantsPing Rawson - Chief Financial OfficerJoseph Hazelton ...

Entered into secured credit agreement with Innoviva for $25 million maturing in 2029 LOS ANGELES, May 13, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ...

Biotechnology has enormous potential to solve some of the world’s most pressing challenges in health, food security, and the environment. Yet conventional methods ...

The Global Health Exhibition will feature the return of the NextGen Pitch Competition from October 27 to 30, 2025, at the ...